114 related articles for article (PubMed ID: 1911231)
21. Ceruloplasmin level in women with breast disease. Preliminary results.
Ozyilkan O; Baltali E; Ozyilkan E; Tekuzman G; Kars A; Firat D
Acta Oncol; 1992; 31(8):843-6. PubMed ID: 1290632
[TBL] [Abstract][Full Text] [Related]
22. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Cannistra SA
Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
[No Abstract] [Full Text] [Related]
23. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
Kobayashi H; Ohi H; Fujii T; Terao T
Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
[TBL] [Abstract][Full Text] [Related]
24. Low frequency and low level of elevation of serum CA 72-4 in human carcinomas in comparison with established tumor markers.
Wu JT; Carlisle P
J Clin Lab Anal; 1992; 6(1):59-64. PubMed ID: 1542085
[TBL] [Abstract][Full Text] [Related]
25. Review of clinical studies of CA 27.29 in breast cancer management.
Beveridge RA
Int J Biol Markers; 1999; 14(1):36-9. PubMed ID: 10367248
[TBL] [Abstract][Full Text] [Related]
26. Echography and CA 125 in ovarian pathology. Preliminary data of a new score.
Foglia M; Verri PG; Calabrese A; Corongiu F; Tarani A; Margiaria ML; De Pascale A; Tagliati D
J Nucl Med Allied Sci; 1990; 34(4 Suppl):67-70. PubMed ID: 2092152
[No Abstract] [Full Text] [Related]
27. Experience with positron emission tomography (PET) scans in patients with ovarian cancer.
Casey MJ; Gupta NC; Muths CK
Gynecol Oncol; 1994 Jun; 53(3):331-8. PubMed ID: 8206407
[TBL] [Abstract][Full Text] [Related]
28. [Comparative studies of the prognostic relevance of tumor markers in ovarian cancer].
Dörffler P; Caffier H
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():293-5. PubMed ID: 8118321
[No Abstract] [Full Text] [Related]
29. Breast cancer marker Ca549. A multicenter study.
Chan DW; Beveridge RA; Bhargava A; Wilcox PM; Kennedy MJ; Schwartz MK
Am J Clin Pathol; 1994 Apr; 101(4):465-70. PubMed ID: 8160638
[TBL] [Abstract][Full Text] [Related]
30. CA-125 is not a useful marker in metastatic breast cancer.
Seckl MJ; Rustin GJ; Coombes RC
Br J Cancer; 1992 Nov; 66(5):875-6. PubMed ID: 1419631
[No Abstract] [Full Text] [Related]
31. Serum level of cryptic tumor antigens in breast cancer patients as determined by two monoclonal antibodies (M85/F36) and its comparison with CA 15-3.
Chu TM; Constantine R; Nemoto T
J Clin Lab Anal; 1989; 3(5):267-72. PubMed ID: 2681619
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunoscintigraphy of ovarian cancer.
Granowska M; Britton KE
Dis Markers; 1991; 9(3-4):191-5. PubMed ID: 1725973
[No Abstract] [Full Text] [Related]
33. Screening for early ovarian cancer.
Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S
Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556
[TBL] [Abstract][Full Text] [Related]
34. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
35. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
[No Abstract] [Full Text] [Related]
36. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
[TBL] [Abstract][Full Text] [Related]
37. Ovarian cancer screening.
van Nagell JR
Cancer; 1991 Aug; 68(4):679-80. PubMed ID: 1855166
[No Abstract] [Full Text] [Related]
38. [Tumour markers of pancreatic cancer (tumour associated antigens)].
Groblewska M; Mroczko B; Szmitkowski M
Pol Arch Med Wewn; 2005 Jun; 113(6):585-93. PubMed ID: 16454450
[No Abstract] [Full Text] [Related]
39. [Tumor markers in the follow-up of colorectal cancers].
Richelme H; Chazal M; Namer M; Benchimol D
Chirurgie; 1993-1994; 119(6-7):346-8. PubMed ID: 7805492
[TBL] [Abstract][Full Text] [Related]
40. Screening for ovarian cancer.
Powell MA
J Am Acad Nurse Pract; 1992; 4(1):36-7. PubMed ID: 1605991
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
